Forsythiaside A improves Influenza A virus infection through TLR7 signaling pathway in the lungs of mice

[1]  Zhao Jia,et al.  Forsythiaside A alleviates methotrexate-induced intestinal mucositis in rats by modulating the NLRP3 signaling pathways , 2022, International Immunopharmacology.

[2]  Mengting Zhou,et al.  Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS , 2022, Oxidative Medicine and Cellular Longevity.

[3]  Cheng Wang,et al.  A review of pharmacological and pharmacokinetic properties of Forsythiaside A. , 2021, Pharmacological research.

[4]  Joseph M. Campos,et al.  Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children , 2020, JAMA network open.

[5]  Peng Wang,et al.  A review on the structure and pharmacological activity of phenylethanoid glycosides. , 2020, European journal of medicinal chemistry.

[6]  Naihua Hu,et al.  Exploration of anti-inflammatory mechanism of forsythiaside A and forsythiaside B in CuSO4-induced inflammation in zebrafish by metabolomic and proteomic analyses , 2019, Journal of Neuroinflammation.

[7]  Zhenyou Jiang,et al.  Effect of Forsythiaside A on the RLRs Signaling Pathway in the Lungs of Mice Infected with the Influenza A Virus FM1 Strain , 2019, Molecules.

[8]  Stephen J. Huang,et al.  Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection , 2019, Nature Communications.

[9]  Yan-Ling Wang,et al.  Forsythiaside A protects against focal cerebral ischemic injury by mediating the activation of the Nrf2 and endoplasmic reticulum stress pathways. , 2019, Molecular medicine reports.

[10]  Jing Yang,et al.  Sodium ferulate protects against influenza virus infection by activation of the TLR7/9-MyD88-IRF7 signaling pathway and inhibition of the NF-κB signaling pathway. , 2019, Biochemical and biophysical research communications.

[11]  G. Teti,et al.  The dual role of innate immunity during influenza , 2019, Biomedical journal.

[12]  Zhenyou Jiang,et al.  Anti‐influenza activity of berberine improves prognosis by reducing viral replication in mice , 2018, Phytotherapy research : PTR.

[13]  S. Crotty.  Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment? Complexities of Interpretation due to the Heterogeneity of Memory CD4 T Cells, Including T Follicular Helper Cells. , 2018, Cold Spring Harbor perspectives in biology.

[14]  G. Lee,et al.  The Balance of Th17 versus Treg Cells in Autoimmunity , 2018, International journal of molecular sciences.

[15]  Menghua Liu,et al.  Forsythiae Fructus: A Review on its Phytochemistry, Quality Control, Pharmacology and Pharmacokinetics , 2017, Molecules.

[16]  T. Tenson,et al.  Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis , 2017, Viruses.

[17]  T. Seya,et al.  Recognition of Viral RNA by Pattern Recognition Receptors in the Induction of Innate Immunity and Excessive Inflammation During Respiratory Viral Infections. , 2017, Viral immunology.

[18]  Lin Zhou,et al.  Forsythoside A exerts an anti-endotoxin effect by blocking the LPS/TLR4 signaling pathway and inhibiting Tregs in vitro. , 2017, International journal of molecular medicine.

[19]  X. Weng,et al.  Forsythoside A Inhibits BVDV Replication via TRAF2-Dependent CD28–4-1BB Signaling in Bovine PBMCs , 2016, PloS one.

[20]  Xiao-yin Chen,et al.  Forsythoside A Controls Influenza A Virus Infection and Improves the Prognosis by Inhibiting Virus Replication in Mice , 2016, Molecules.

[21]  Hongfei Zhao,et al.  Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway , 2016, Neurochemical Research.

[22]  Aiping Wu,et al.  Antigenic Patterns and Evolution of the Human Influenza A (H1N1) Virus , 2015, Scientific Reports.

[23]  L. Cheng,et al.  Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-κB. , 2015, International immunopharmacology.

[24]  B. Cowling,et al.  Influenza: the rational use of oseltamivir , 2015, The Lancet.

[25]  Hye-Ri Kang,et al.  Phosphatidylinositol‐3‐kinase and Akt are required for RIG‐I‐mediated anti‐viral signalling through cross‐talk with IPS‐1 , 2015, Immunology.

[26]  Z. Yao,et al.  Influenza A(H1N1) vaccination during early pregnancy transiently promotes hippocampal neurogenesis and working memory. Involvement of Th1/Th2 balance , 2014, Brain Research.

[27]  K. Kedzierska,et al.  Suppressor of Cytokine Signaling 4 (SOCS4) Protects against Severe Cytokine Storm and Enhances Viral Clearance during Influenza Infection , 2014, PLoS pathogens.

[28]  Yuan Zhang,et al.  Erratum to: Th1/Th2 Cell Differentiation and Molecular Signals. , 2014, Advances in Experimental Medicine and Biology.

[29]  S. Bashiardes,et al.  Molecular epidemiology of influenza A virus infection in Cyprus in four consecutive seasons (2009 pandemic–2013) , 2013, Epidemiology and Infection.

[30]  Guojuan Wu,et al.  Forsythoside a inhibits the avian infectious bronchitis virus in cell culture , 2010, Phytotherapy research : PTR.

[31]  Yan Wang,et al.  Antioxidant and antibacterial activity of two compounds (forsythiaside and forsythin) isolated from Forsythia suspensa , 2008, The Journal of pharmacy and pharmacology.

[32]  S. Nishibe,et al.  The Structure of Forsythiaside isolated from Forsythia suspensa , 1982 .